
Digital neurology solutions from compassionate hearts and bright minds
Headquarters: Uppsala, Sweden
Sector: Software as a Medical Device (neurology & psychiatry)
Employee count: 30
Clinical activity: U.S. clinical studies initiated (collaboration with Dartmouth Hitchcock Medical Center)
Notable investor: VNV Global (lead investor in multiple rounds)
Neurology and psychiatry — diagnostic support, digital biomarkers, and clinical decision support
2015
Digital Health / Medical Software (SaMD)
SEK 10 million
Press release states completion of a share issue with VNV Global as lead investor.
SEK 10 million
Announcement of an additional investment by VNV Global.
approx. SEK 15 million
Company completed a new share issue with participation from VNV Global and university-related investors.
“VNV Global identified as recurring lead investor; other investors include Uppsala University Invest AB (Uppsala University Holding), Stockholm University Holding AB, Linnea Capital and the Beijer Foundation.”